碳离子与调强放疗后患者辐射诱导染色体畸变的持续性
该研究对14例接受碳离子 boost 联合调强放疗的前列腺癌患者,于治疗结束即刻、1年及2.5年时分析外周血淋巴细胞染色体畸变。双着丝粒染色体降至初始值约40%,易位保持不变,畸变谱向易位偏移提示造血干/祖细胞受照。
要点
- 双着丝粒染色体在治疗后1年和2.5年降至初始值约40%(p=0.011和p=0.001)。
- 易位产率在随访期间保持不变,与双着丝粒染色体诱导频率相等。
- 2例患者观察到克隆性畸变,但治疗前样本中亦存在,非放疗诱导。
核心结论
- 畸变谱向易位比例增高偏移,提示造血干/祖细胞受到照射,强调放疗中仔细保护骨髓以降低继发癌症风险的重要性。
研究设计与样本
- 对14例接受碳离子 boost 联合调强放疗的前列腺癌患者,于治疗结束即刻、1年及2.5年采集外周血淋巴细胞,用多重荧光原位杂交技术评分染色体畸变并按可传递给子细胞与否分组。
主要发现
- 双着丝粒染色体(不可传递)与易位(可传递)诱导频率相等。
- 随访期间易位产率保持不变,而双着丝粒染色体产率降至初始值约40%(治疗结束相比,1年 p=0.011,2.5年 p=0.001)。
- 2例患者观察到克隆性畸变,但治疗前样本中亦发现,故非放疗诱导。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Chromosomal aberrations in peripheral blood lymphocytes are a biomarker for radiation exposure and are associated with an increased risk for malignancies. To determine the long-term cytogenetic effect of radiotherapy, we analyzed the persistence of different aberration types up to 2.5 years after the treatment. MATERIALS AND METHODS: Cytogenetic damage was analyzed in lymphocytes from 14 patients that had undergone C-ion boost + IMRT treatment for prostate cancer. Samples were taken immediately, 1 year and 2.5 years after therapy. Aberrations were scored using the multiplex fluorescence in situ hybridization technique and grouped according to their transmissibility to daughter cells. RESULTS: Dicentric chromosomes (non-transmissible) and translocations (transmissible) were induced with equal frequencies. In the follow-up period, the translocation yield remained unchanged while the yield of dicentrics decreased to ≈40% of the initial value (p = 0.011 and p = 0.001 for 1 and 2.5 years after compared to end of therapy). In 2 patients clonal aberrations were observed; however they were also found in samples taken before therapy and thus were not radiotherapy induced. CONCLUSION: The shift in the aberrations spectrum towards a higher fraction of translocations indicates the exposure of hematopoietic stem and progenitor cells underlining the importance of a careful sparing of bone marrow during radiotherapy to minimize the risk for secondary cancers.
引用
- Hartel C, Nasonova E, Fuss MC, et al. Persistence of radiation-induced aberrations in patients after radiotherapy with C-ions and IMRT. Clin Transl Radiat Oncol. 2018. PMID: 30364751. doi:10.1016/j.ctro.2018.10.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。